Edition:
United Kingdom

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

1.16USD
18 Jan 2019
Change (% chg)

$0.05 (+4.50%)
Prev Close
$1.11
Open
$1.11
Day's High
$1.19
Day's Low
$1.11
Volume
34,607
Avg. Vol
59,321
52-wk High
$5.15
52-wk Low
$0.60

Latest Key Developments (Source: Significant Developments)

Curis Announces Leadership Change
Monday, 24 Sep 2018 

Sept 24 (Reuters) - Curis Inc ::CURIS ANNOUNCES LEADERSHIP CHANGE.CURIS INC - COMPANY APPOINTS JAMES DENTZER PRESIDENT AND CEO.CURIS INC - DENTZER WILL BECOME A MEMBER OF CURIS BOARD OF DIRECTORS.CURIS INC - DENTZER REPLACES ALI FATTAEY WHO IS LEAVING COMPANY..  Full Article

Curis Reports Q2 Loss Per Share $0.26
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - Curis Inc ::CURIS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 REVENUE $2.4 MILLION VERSUS I/B/E/S VIEW $2.3 MILLION.Q2 LOSS PER SHARE $0.26.Q2 EARNINGS PER SHARE VIEW $-0.39 -- THOMSON REUTERS I/B/E/S.  Full Article

Curis Announces FDA Fast Track Designation For Fimepinostat (Cudc-907) Development
Thursday, 31 May 2018 

May 31 (Reuters) - Curis Inc ::CURIS ANNOUNCES FDA FAST TRACK DESIGNATION FOR FIMEPINOSTAT (CUDC-907) DEVELOPMENT IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA.  Full Article

Curis Inc says Q3 loss per share $0.11
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Curis Inc -:Curis reports third quarter 2017 financial results.Q3 revenue $2.4 million versus I/B/E/S view $2.2 million.Q3 loss per share $0.11.Q3 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.Curis Inc - ‍announce Acceptance Of Investigational New Drug (IND) application for CA-4948​.  Full Article